HeadlinesBriefing favicon HeadlinesBriefing.com

Sanofi CEO Faces Investor Scrutiny After R&D Shift

Companies •
×

Sanofi CEO Paul Hudson is facing pressure to deliver on a revamped research and development (R&D) strategy. Hudson admitted to investors that he underestimated the time it would take to execute the company's new strategic direction. The French pharmaceutical giant's shift aims to streamline operations and focus on more promising drug candidates, a move that hasn't yet fully convinced shareholders.